RNAi Outsider Senetek Looking for Pharma Partner to Develop, Sell Its Brain Cancer Rx

/Home/Biologics Delivery - Protein Synthesis/RNA - Protein Synthesis/RNAi - Protein Synthesis

RNAi Outsider Senetek Looking for Pharma Partner to Develop, Sell Its Brain Cancer Rx
By Doug Macron
November 30, 2006
RNAi News
Armed with an in-licensed RNAi-based brain cancer drug, Senetek concedes it has ?no capabilities? to develop it but hopes to find a partner from among its ?significant relationships with pharmaceutical companies? that can develop and commercialize the product.
Paid subscription is required to view article.